induction by fertility doctors since 2001; having less side-effects than clomiphene citrate (Clomid®) for the patient. A Canadian study presented at the American Society of Reproductive Medicine 2005 Conference suggests that it may increase femara breast cancer drug risk of birth defects compared with a femara breast cancer drug group.

J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF. Congenital malformations among 911 newborns conceived after infertility treatment with femara breast cancer drug or clomiphene citrate. femara breast cancer drug Steril. 2006 Apr 28. PMID 16650422^ femara breast cancer drug ESHRE abstract LetrozoleFrom femara breast cancer drug the free encyclopedia(Redirected from Femara)Jump to: navigation, searchLetrozoleSystematic (IUPAC) name4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrileIdentifiersCAS number 112809-51-5ATC code L02BG04PubChem 3902DrugBank APRD01066Chemical dataFormula C17H11N5Mol. mass 285.303 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability 99.9%Protein binding 60%, mainly to albuminMetabolism ?Half life 2 daysExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ?(CA)Routes ?Letrozole (INN, trade name Femara®) femara breast cancer drug an oral non-steroidal aromatase inhibitor that has been used for ovulation induction femara breast cancer drug fertility doctors since 2001; having less side-effects than clomiphene citrate.

to treat endometriosis.[2][edit] References^ Tulandi T, Martin J, Al-Fadhli R, Kabli N, femara breast cancer drug R, Hitkari J, Librach C, Greenblatt Librach.